Previous 10 | Next 10 |
Strongbridge Biopharma (NASDAQ: SBBP ) -16% after pricing $25M share offering. More news on: Strongbridge Biopharma plc, NuCana plc, Dave & Buster's Entertainment, Inc., Stocks on the move, , Read more ...
Live video webcast with CEO, Jeffrey Eisenberg, on Wednesday, September 16 th at 12:00 PM EDT FRAMINGHAM, MA / ACCESSWIRE / September 9, 2020 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a ...
CureVac (NASDAQ: CVAC ) +47% on making reasonable profit on COVID-19 vaccine. More news on: CureVac N.V., LMP Automotive Holdings, Inc., Microbot Medical Inc., Stocks on the move, , Read more ...
Xenetic Biosciences (NASDAQ: XBIO ) : Q2 GAAP EPS of -$0.15 beats by $0.07 . Revenue of $0.11M beats by $0.05M . Press Release More news on: Xenetic Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, ,
- Successfully established two strategic academic collaborations in Q2 2020 to advance development of XCART™, its differentiated CAR T therapy platform - - Strengthened panel of experts on the Scientific Advisory Board, bringing valuable expertise across all phases of preclinical and ...
Jia Xie, PhD, a prominent researcher at Scripps Research responsible for inventing a collection of new technologies for antibody drug discovery and cell therapy Alexey V. Stepanov, PhD, a leading research expert in developing personalized therapeutic tools for lymphoproliferative disea...
4 Penny Stocks To Watch Amid New Record Numbers In July Here we are at the start of a new week and coronavirus penny stocks remain in focus. While the stock market rally stutter-stepped a bit, it hasn’t seen COVID-related names stall. Investors are looking at another pending stimulus...
DPW Holdings (NYSEMKT: DPW ) +136% on introducing a new product line of electric vehicle chargers. More news on: DPW Holdings, Inc., Sonnet BioTherapeutics Holdings, Inc., Volt Information Sciences, Inc., Stocks on the move, , Read more ...
XCART technology platform is a significantly differentiated, proprietary approach to personalized CAR T therapy for the treatment of multiple tumor types of B-cell Non-Hodgkin lymphoma (NHL) Recently secured two academic collaborations to advance development of XCART Company strat...
Mid-Con Energy Partners (NASDAQ: MCEP ) +154% on Q1 results . More news on: Mid-Con Energy Partners, LP, IDEAYA Biosciences, Inc., iQIYI, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Xenetic Biosciences Inc. Company Name:
XBIO Stock Symbol:
NASDAQ Market:
Xenetic Biosciences Inc. Website:
Company's Board of Directors Appoint James F. Parslow to Interim Chief Executive Officer FRAMINGHAM, MA / ACCESSWIRE / May 22, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technolog...
Ongoing preclinical studies with multiple data readouts expected throughout remainder of 2024 Continued advancement of DNase-based oncology program towards Phase 1 clinical study for the treatment of pancreatic carcinoma and other locally advanced or metastatic solid tumors Ended the qu...
Continued advancement of DNase-based oncology program towards Phase 1 clinical study for the treatment of pancreatic carcinoma and other locally advanced or metastatic solid tumors Ended the year with $9.0 million of cash to fund operations FRAMINGHAM, MA / ACCESSWIRE / March 22, 2024 /...